Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy

American Journal of Nephrology

Volumn 20, Issue 3, 2000, Pages 180-186

  Małyszko, Jolanta ^a   Zbroch, Edyta ^a   Wołczyński, Sławomir ^a   Małyszko, Jacek S ^a   Hryszko, Tomasz ^a   Myśliwiec, Michał ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cytokines; Erythropoietin; Hemodialysis; Leptin; Peritoneal dialysis; PTH

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; ERYTHROPOIETIN; INTERLEUKIN 1; LEPTIN; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PERITONEAL FLUID; PRIORITY JOURNAL; ULTRAFILTRATION; UREMIA;

EID: 0343090803     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013581     Document Type: Article

References (26)

1. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM: Positional cloning of the mouse oh gene and its human homologue. Nature 1994;372:425-432.
2. Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D. Snodgrass HR: Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585-589.
3. Mikhail AA, Beck EX, Shafer A, Barut B, Smith-Gbur J, Zupancic TJ, Schweitzer AC, Cioffi JA, Lacaud G, Ouyang B, Keller G, Snodgrass HR: Leptin stimulates fetal and adult erythroid myeloid development. Blood 1997;5:1507-1512.
4. MacDougall IC: Poor response to erylhropoietin: Practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10:607-614.
5. Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W: A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170-1180.
6. Steinvinkel P, Heimburger O, Lonnqvist F, Barany P: Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? Kidney Int 1998;53:1430-1431.
7. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, Steinvinkel P: Serum immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-1430.
8. Grunfeld C, Zhao C, Fuller J, Pollock A, Moser A, Friedman J, Feingold KR: Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97:2152-2157.
9. Fouque D, Juillard L, Lasne Y, Tabakian A, Laville M, Joly MO, Laville M: Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-1. Kidney Int 1998; 54:932-937.
10. Valderrabano F: Erythropoietin in chronic renal failure. Kidney Int 1996;50:90-96.
11. Levin NW: Quality of life and hematocrit level. Am J Kidney Dis 1992;20(suppl 1):16-20.
12. Saad MF, Riad Gabriel MG, Khan A, Sharma A, Michael R, Jinagouda SD, Boyadjian R, Steil GM: Diurnal and ultradian rhythmicity of plasma leptin: Effects of gender and adiposity. J Clin Endocrinol Metab 1998;83:453-549.
13. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42: 942-946.
14. Fei H, Okano H, Li C, Lee GH, Zhao C, Darnell R, Friedman J: Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997;94:7001-7005.
15. Kokot F, Wiecek A, Mesjasz J, Adamczak M, Spiechowicz U: Influence of long-term recombinant human erythropoictin therapy on plasma leptin and neuropeptide Y concentration in haemodialysed patients. Nephrol Dial Transplant 1998;13:1200-1205.
16. Park JS, Moon KH, Kim SB, Park S, Moon DH, Lee SK: Changes of serum leptin levels after rHuEPO treatment in hemodialysis patients. J Am Soc Nephrol 1998;9:238A.
17. Kagan A, Haran N, Leschinsky L, Shuali N, Rapoport J: Leptin in CAPD patients: Serum concentrations and peritoneal loss. Nephrol Dial Transplant 1999;14:400-405.
18. Barany P: Endocrinology and PD: Optimal treatment of anemia in peritoneal dialysis patients. Perit Dial Int 1996;16(suppl 1):260-266.
19. Sharma K, Considine RV, Michael B, Dunn SR, Wiesberg LS, Kurnik PB, Kurnik BRC, O'Connor J, Sinha M, Caro JF: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 1997;51: 1980-1985.
20. Hillon D, Serazin V, Savoiu C, Giudicelli Y: Leptin removal in dialysis patients: Influence of mode of treatment. J Am Soc Nephrol 1998; 9:400A.
21. Coyne DW, Dagogo-Jack S, Klein S, Merabet E, Audrain J, Landt M: High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. Am J Kidney Dis 1998;32:1031-1035.
22. Heimburger O, Wang T, Lonnqvist F, Steinvinkel P: Peritoneal clearance of leptin in CAPD patients: Impact of local insulin administration. Nephrol Dial Transplant 1999;14: 723-727.
23. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Steinvinkel P: Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998;54: 1267-1275.
24. Kimimel PL, Philips TM, Simmens SJ, Peterson RA, Wiehs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54:236-244.
25. Canivet E, Lavaud S, Wong T, Guenounou M, Willemin JC, Potron G, Chanard C: Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor alpha levels during hemodialysis. Am J Kidney Dis 1994;23:41-46.
26. Goicoechea M, Martin J, de Sequera P, Quiroga JA, Ortiz VC, Caramelo C: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 1998;54:1337-1343.